Clinical Trials Directory

Trials / Completed

CompletedNCT02613858

Minimal HePatic Encephalopathy Among CiRrhotics. A Cross SEctional, Clinico-EpidEmiological, Multi-Centre, Study in Patients of PakisTan

Status
Completed
Phase
Study type
Observational
Enrollment
550 (actual)
Sponsor
Abbott · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The Preempt study is likely to help determine the frequency of patients suffering from Minimal Hepatic Encephalopathy (MHE) and are cirrhotics. It will also enable us to know about the Quality of life of these patients.

Conditions

Timeline

Start date
2015-11-01
Primary completion
2017-03-01
Completion
2017-05-01
First posted
2015-11-25
Last updated
2017-05-11

Locations

6 sites across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT02613858. Inclusion in this directory is not an endorsement.